Omeprazol Sandoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Sandoz, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage acid‑related disorders in adults and children when appropriate. GNH USA supplies Omeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Sandoz, a proton pump inhibitor, is indicated for conditions driven by excess gastric acid production. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by maintaining a higher gastric pH. - Erosive oesophagitis: reduces inflammation and allows mucosal recovery. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

Omeprazol Sandoz is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence and belching. - Constipation.

Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhoea. - Severe allergic reactions such as anaphylaxis or angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation or hepatitis. - Hypomagnesemia with prolonged use. - Acute interstitial nephritis.

Before initiating therapy, consider the following safety points. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment: use with caution in patients with liver disease. - Long‑term therapy: monitor for vitamin B12 deficiency and bone density. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk. - Drug‑interaction review: evaluate concomitant medications that may alter acid levels. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Sandoz may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir and other protease inhibitors: decreased antiviral exposure. - HIV protease inhibitors (e.g., ritonavir): diminished efficacy. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum levels. - Phenytoin: reduced clearance leading to higher concentrations. - Fluconazole and other azole antifungals: may increase omeprazole exposure. - Diazepam: enhanced sedation. - Warfarin: monitor INR for potential changes.